Metraipolis › archive › dc_f236bb75de21
Flavonoids for MASLD: Hepatic Lipid Targets, Biopharmaceutic Barriers, and Formulation Strategies — Europe PMC PMID:42797439
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42797439
- DOI
- 10.3390/ph19091393
- License (as archived)
- solo-consultazione
- Archived
- 2026-10-16T06:21:07.317Z
- SHA-256 of the archived text
aacb9fe0e4b5fd32e0374607ec286b9a7a1af2f687fd3669dfdcec8c21ecca58- Stable URL of this page
https://metraipolis.com/documento/dc_f236bb75de21
How to cite
Flavonoids for MASLD: Hepatic Lipid Targets, Biopharmaceutic Barriers, and Formulation Strategies — Europe PMC PMID:42797439 — Europe PMC (en), https://europepmc.org/article/MED/42797439 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_f236bb75de21 (Metraipolis archive dc_f236bb75de21, sha256 aacb9fe0e4b5fd32e0374607ec286b9a7a1af2f687fd3669dfdcec8c21ecca58)
BibTeX
@misc{dcf236bb75de21,
title = {Flavonoids for MASLD: Hepatic Lipid Targets, Biopharmaceutic Barriers, and Formulation Strategies — Europe PMC PMID:42797439},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42797439},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_f236bb75de21; sha256 aacb9fe0e4b5fd32e0374607ec286b9a7a1af2f687fd3669dfdcec8c21ecca58},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42797439. Agents can read the archived copy with the MCP tool read_document.